TY  - JOUR
AU  - Liam, Chong-Kin
PY  - 2018
TI  - The role of osimertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer
JF  - Journal of Thoracic Disease; Vol 11, Supplement 3 (March 12, 2019): Journal of Thoracic Disease
Y2  - 2018
KW  - 
N2  - Activating mutations in the epidermal growth factor receptor (EGFR) gene is the most common driver oncogene in non-small cell lung cancer (NSCLC), being present in up to 60% of Asian patients and up to 20% in Caucasian patients with advanced NSCLC.
UR  - https://jtd.amegroups.org/article/view/25500